Cited by 88Cancer survivorship and careChildhood Cancer Survivors' Quality of LifeAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Re‐validation and screening capacity of the 6‐item version of the Cancer Worry Scale

Open access
Custers, José A.E., Kwakkenbos, Linda, van de Wal, Marieke, Prins, Judith B., Thewes, Belinda·2018·Psycho-Oncology

Abstract

Objective: Fear of cancer recurrence (FCR) is one of the major existential unmet needs of cancer survivors. Due to growing availability of evidenced‐based interventions for high FCR, valid and reliable brief measures of FCR are needed. This study aimed to validate the 6‐item Cancer Worry Scale (CWS) and to establish a cut‐off score for high FCR. Methods: Participants in this study were 1033 cancer survivors and patients recruited as part of 5 existing studies on FCR involving patients and survivors with gastro‐intestinal stromal tumors, colorectal, breast, and prostate cancer. De‐identified data of the CWS, Fear of Cancer Recurrence Inventory (FCRI), Impact of Event Scale, Hospital Anxiety and Depression Scale, and EORTC‐QLQ‐C30 were amalgamated for the analyses. Confirmatory factor analysis of the CWS was performed. Sensitivity and specificity were tested with the FCRI as gold standard. Results: Results confirmed that the 6‐item version of the CWS maintained good construct validity, convergent and divergent validity, and high internal consistency (α 0.90). The optimal cut‐off for the 6‐item CWS was 9 versus 10 using the 12 vs 13 FCRI‐SF score (sensitivity 82%, specificity 83%) and the 15 vs 16 FCRI‐SF score (sensitivity 88%, specificity 73%). Using the highest FCRI‐SF cut‐off (21 vs 22), the optimal CWS cut‐off was 11 vs 12 (sensitivity 88%, specificity 81%). Conclusions: The present results provide researchers and clinicians with a brief valid and reliable measure of FCR which is suitable for measuring FCR in cancer patients and survivors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pon.4782

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The 6-item version of the CWS has good construct, convergent and divergent validity, and high internal consistency to detect fear of cancer recurrence in breast cancer survivors, with a Cronbach alpha coefficient of 0.90.

    “The 6-item version of the CWS has good construct, convergent and divergent validity, and high internal consistency to detect fear of cancer recurrence in breast cancer survivors, with a Cronbach alpha coefficient of 0.90 (Custers et al., 2018).”

    From A randomised controlled trial comparing internet-delivered cognitive behavioural therapy (iCBT) with and without main carer access versus treatment-as-usual for depression and anxiety among breast cancer survivors: Study protocol (2021) · cites this paper as Custers et al., 2018

    The Abstract and §3.2 report good construct, convergent and divergent validity and high internal consistency for the 6-item CWS, with Cronbach’s alpha of 0.90. But §2.1 says the analysis pooled patients and survivors with several cancer types, including breast cancer; the cited results are not specific to breast cancer survivors. Page numbers are unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The Cancer Worry Scale is well-validated for assessing fear of recurrence in cancer patients and survivors.

    “The Cancer Worry Scale is a 6-item self-report measure designed to assess fear of recurrence in cancer survivors that has been well-validated for use in cancer patients and survivors.33”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Custers JAE, Gielissen MFM, de Wilt JHW, Prins JB. Fear of cancer recurrence, quality of life and distress in the first year after the diagno- sis of colorectal cancer. Psychooncology. 2015;24(2):91.

Cited by

Sorted by citations

Authors
Custers, J. A. E., Kwakkenbos, L., van de Wal, M., Prins, J. B., & Thewes, B.
Affiliations
  • Radboud University Medical Center (NL)
  • Radboud University Nijmegen (NL)
  • Radboud Institute for Health Sciences, Department of Medical Psychology Radboud University Medical Center Nijmegen The Netherlands
Corresponding author
Custers, José A.E.
Venue
Psycho-Oncology
Publisher
Wiley
Published
2018-06-14
Volume
27
Issue
11
Pages
2609-2615
ISSN
  • 1057-9249 (ISSN-L)
  • 1099-1611
OpenAlex
W2807241313
Cited by
88
References
32
Citations by year
2026: 12 · 2025: 16 · 2024: 15 · 2023: 10 · 2022: 20 · 2021: 11 · 2020: 3 · 2018: 1
FWCI
1.41
Type
journal article
Language
en
Open access
Locations
  • Psycho-Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
fear of cancer recurrence, scale validation, cancer survivors, psychometric properties, cut-off values, gastrointestinal stromal tumor, breast cancer, colorectal cancer, prostate cancer
MeSH terms
Cancer Survivors, Adult, Anxiety, Fear, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Phobic Disorders, Psychometrics, Quality of Life, Surveys and Questionnaires, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review